Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer.
Wang Y, Min J, Deng X, Feng T, Hu H, Guo X, Cheng Y, Xie B, Yang Y, Chen CC, Guo RT, Dong C, Zhou HB.
Wang Y, et al. Among authors: cheng y.
Acta Pharm Sin B. 2023 Dec;13(12):4963-4982. doi: 10.1016/j.apsb.2023.05.005. Epub 2023 May 12.
Acta Pharm Sin B. 2023.
PMID: 38045063
Free PMC article.